Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$76.73 - $120.62 $132,512 - $208,310
-1,727 Reduced 9.13%
17,188 $2.01 Million
Q3 2023

Nov 14, 2023

BUY
$84.17 - $161.17 $42,421 - $81,229
504 Added 2.74%
18,915 $1.66 Million
Q2 2023

Aug 11, 2023

BUY
$155.24 - $196.47 $364,037 - $460,722
2,345 Added 14.6%
18,411 $3.03 Million
Q1 2023

May 15, 2023

BUY
$146.03 - $184.54 $52,278 - $66,065
358 Added 2.28%
16,066 $2.96 Million
Q4 2022

Feb 09, 2023

BUY
$110.88 - $150.36 $38,697 - $52,475
349 Added 2.27%
15,708 $2.32 Million
Q3 2022

Nov 14, 2022

SELL
$125.58 - $169.38 $119,552 - $161,249
-952 Reduced 5.84%
15,359 $2.17 Million
Q2 2022

Aug 12, 2022

BUY
$112.97 - $151.71 $3,050 - $4,096
27 Added 0.17%
16,311 $2.13 Million
Q1 2022

May 13, 2022

BUY
$135.71 - $284.87 $249,570 - $523,875
1,839 Added 12.73%
16,284 $2.37 Million
Q4 2021

Oct 18, 2022

BUY
$266.41 - $303.29 $89,513 - $101,905
336 Added 2.38%
14,445 $4.23 Million
Q4 2021

Jan 18, 2022

BUY
$266.41 - $303.29 $89,513 - $101,905
336 Added 2.38%
14,445 $4.23 Million
Q2 2021

Oct 18, 2022

SELL
$208.49 - $248.2 $459,094 - $546,536
-2,202 Reduced 13.5%
14,109 $3.42 Million
Q1 2021

Oct 17, 2022

SELL
$220.31 - $283.75 $485,122 - $624,817
-2,202 Reduced 13.5%
14,109 $3.24 Million
Q1 2021

Apr 13, 2021

BUY
$220.31 - $283.75 $155,538 - $200,327
706 Added 5.27%
14,109 $3.24 Million
Q4 2020

Jan 29, 2021

BUY
$223.82 - $271.35 $161,598 - $195,914
722 Added 5.69%
13,403 $3.6 Million
Q3 2020

Nov 04, 2020

BUY
$209.49 - $246.81 $2.66 Million - $3.13 Million
12,681 New
12,681 $2.95 Million

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $9.04B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.